Perret G, Hugues J N, Modigliani E, Sebaoun J
Int J Clin Pharmacol Ther Toxicol. 1984 Jul;22(7):360-4.
An open randomized study involving 57 subjects, 40 euthyroid and 17 hyperthyreotic, was undertaken to compare the effect of two beta-adrenergic blocking drugs, propranolol (120 mg/day) and acebutolol (600 mg/day), on the thyroid hormones serum level. In hyperthyreotic as well as in euthyroid subjects, propranolol evoked a fall in T3, an increase in reverse T3 and therefore a decrease in the T3/rT3 ratio. Acebutolol caused a decrease in T3 and in the T3/rT3 ratio only in euthyroid subjects. The only significant variation in the hyperthyroid acebutolol treated group was a decrease in reverse T3, perhaps spontaneous. TBG and TSH concentrations remained stable under treatment in all the groups. The relation of these effects with the existence of a membrane stabilizing activity displayed by propranolol as well as by acebutolol is discussed.
一项涉及57名受试者(40名甲状腺功能正常者和17名甲状腺功能亢进者)的开放性随机研究,旨在比较两种β-肾上腺素能阻滞剂普萘洛尔(120毫克/天)和醋丁洛尔(600毫克/天)对甲状腺激素血清水平的影响。在甲状腺功能亢进者和甲状腺功能正常者中,普萘洛尔均引起T3下降、反T3升高,从而导致T3/反T3比值降低。醋丁洛尔仅在甲状腺功能正常者中导致T3和T3/反T3比值降低。在接受醋丁洛尔治疗的甲状腺功能亢进组中,唯一显著的变化是反T3下降,可能是自发性的。在所有组中,治疗期间TBG和TSH浓度保持稳定。讨论了这些效应与普萘洛尔和醋丁洛尔所表现出的膜稳定活性之间的关系。